Boardroom Alpha
Start trial
8-K primary document
UPXI · Current Report (Form 8-K) · Filed May 7, 2026

Upexi Inc — 8-K exhibit

upxi_ex992.htm
Upexi Inc on Boardroom Alpha
upxi_ex992.htm

EXHIBIT 99.2

 

Upexi Provides Periodic Update to its Share Repurchase Program

 

TAMPA, FL., May 6, 2026 -- Upexi, Inc. (NASDAQ: UPXI) (“Upexi” or the “Company”), a leading Solana-focused digital asset treasury company and consumer brands owner, provided an update to the $50,000,000 authorized share repurchase program, previously announced on November 13, 2025.

 

Year-to-Date Share Repurchases

 

Trade month

 

Number of common shares purchased

 

 

Average price per share excluding fees

 

 

Consideration excluding fees

 

January 2026

 

 

 -

 

 

 $ -

 

 

 $ -

 

February 2026

 

 

 1,637,500

 

 

 $ 0.76

 

 

 $ 1,246,450.70

 

March 2026

 

 

 840,561

 

 

 $ 0.87

 

 

 $ 728,230.80

 

April 2026

 

 

 -

 

 

 $ -

 

 

 $ -

 

Total

 

 

 2,478,061

 

 

 $ 0.80

 

 

 $ 1,974,681.50

 

 

As of May 5, 2026, the Company has repurchased a total of 2,894,287 shares of the Company’s common stock and has $47,226,036 remaining on its share repurchase program.  Management will provide periodic updates to the share repurchase program through press releases and annual and quarterly financial reports.  

 

Management will continue to use the share repurchase program and other available tools to maximize shareholder value. 

 

About Upexi, Inc.

Upexi, Inc. (Nasdaq: UPXI) is a leading digital asset treasury company, where it aims to acquire and hold as much Solana (SOL) as possible in a disciplined and accretive fashion. In addition to benefiting from the potential price appreciation of Solana, the cryptocurrency of the leading high-performance blockchain, Upexi utilizes three key value accrual mechanisms in intelligent capital issuance, staking, and discounted locked token purchases. The Company operates in a risk-prudent fashion to position itself for any market environment and to appeal to investors of all kinds, and it currently holds roughly 2.4 million SOL. Upexi also continues to be a brand owner specializing in the development, manufacturing, and distribution of consumer products. Please see www.upexi.com for more information.

 

Follow Upexi on X - https://x.com/upexitreasury

Follow CEO, Allan Marshall, on X - https://x.com/upexiallan

Follow CSO, Brian Rudick, on X - https://x.com/thetinyant

 

Company Contact

Brian Rudick, Chief Strategy Officer

(203) 442-5391

brian.rudick@upexi.com

 

Investor Relations Contact

KCSA Strategic Communications

Valter Pinto or Jack Perkins

Upexi@KCSA.com

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer